An overview: Human Polyomavirus JC Virus and its Associated Disorders

References

• Alwine (1982). Evidence for simian virus 40 late transcrip-tional control: mixed infection of wild-type simian virus 40 and a leader deletion mutant exhibit trans effects on late viral RNA synthesis. J Virol 37: 730–737.
   Google Scholar
• Amemiya K, Traub R, Durham L, Major EO (1989). Interac-tion of a nuclear factor-1-like protein with the regulatory region of the human polyomavirus JC virus. J Biol Chem 264: 7025–7032.
   PubMedGoogle Scholar
• Astrom KE, Mancall EL, Richardson EP Jr (1958). Progres-sive multifocal encephalophathy: a hitherto unrecog-nized complication of chronic lymphocytic leukemia and lymphoma. Brain 81: 99–111.
   Google Scholar
• Beggs AH, Frisque RJ, Scangos GA (1988). Extinction of JC virus tumor-antigen expression in glial cell-fibroblast hybrids. Proc Natl Acad Sci US A 85: 7632–7636.
   Google Scholar
• Beggs AH, Miner JH, Scangos GA (1990). Cell type-specific expression of JC virus T antigen in primary and estab-lished cell lines from transgenic mice. J Gen Virol 71: 151–164.
   Google Scholar
• Berger JR, Concha M (1995). Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J NeuroVirol 1: 5–18.
   PubMed Web of Science ®Google Scholar
• Berger JR, Kaszovitz B, Post JD, Dickinson G (1987). Pro-gressive multifocal encephalopathy associated with hu-man immunodeficiency virus infection: a review of the literature with a report of sixteen cases. Ann Int Med 107: 78–87.
   PubMed Web of Science ®Google Scholar
• Bollag B, Chuke WF, Frisque RJ (1989). Hybrid genomes of the polyomaviruses JC virus, BK virus, and simian virus 40: identification of sequences important for efficient transformation. J Virol 63: 863–872.
   PubMedGoogle Scholar
• Brooks BR, Walker DL (1984). Progressive multifocal en-cephalopathy. Neurol Clin 2: 299–313.
   PubMed Web of Science ®Google Scholar
• Carswell S, Alwine JC (1986). Simian virus 40 agnoprotein facilitates perinuclear-nuclear localization of VP1, the major capsid protein. J Virol 60: 1055–1061.
   PubMed Web of Science ®Google Scholar
• Carswell S, Resnick J, Alwine JC (1986). Construction and characterization of CV-1P cell lines which constitutively express the simian virus 40 Agnoprotein: alteration of plaguing phenotype of viral Agnoproteingene mutants. J Virol 60: 415–422.
   PubMedGoogle Scholar
• Castoigna P, Rondot P, Escourolle R, Ribadeau-Dumas JL, Catala F, Hauw JJ (1974). Leukoencephalopathie mul-tifocale progressive et "glomes" multiples. Rev Neurol 130: 379–392.
   Google Scholar
• Chen NN, Chang CF, Gallia GL, Kerr DA, Johnson EM, Krachmarov CP, Barr SM, Frisque RJ, Bollag B, Khalili K (1995). Cooperative action of cellular proteins YB-1 and Pur alpha with the tumor antigen of the human JC polyomavirus determines their interaction with the vi-ral lytic control element. Proc Natl Acad Sci U S A 92: 1087–1091.
   PubMedGoogle Scholar
• Chen NN, Khalili K (1995). Transcriptional regulation of human JC polyomavirus promoters by cellular proteins YB-1 and Pur alpha in glial cells. J Virol 69: 5843–5848.
   PubMedGoogle Scholar
• Chowdhury M, Taylor JP, Chang CF, Rappaport J, Khalili K (1992). Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat. J Virol 66: 7355–7361.
   PubMedGoogle Scholar
• Cullen BR (1990). The HIV-1 Tat protein: as RNA specific processivity factor? Cell 63: 655–657.
   Google Scholar
• Dyson N, Buchkovich KP, Whyte P, Harlow E (1989). The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 58: 249–255.
   PubMedGoogle Scholar
• Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F (1990). Tat protein of HIV stimulates growth of Kaposi's sarcoma lesion of AIDS patients. Nature 345: 84–86.
   PubMed Web of Science ®Google Scholar
• Feigenbaum L, Hinrichs SH, Jay G (1992). JC virus and simian virus 40 enhancers and transforming proteins: role in determining tissue specificity and pathogenicity in transgenic mice. J Virol 66: 1176–1182.
   PubMedGoogle Scholar
• Feigenbaum L, Khalili K, Major EO, Khoury G (1987). Regu-lation of the host range of human papovavirus JCV. Proc Nail Acad Sci US A 84: 3695–3698.
   Google Scholar
• Frankel AD (1992). Activation of HIV transcription by Tat. Curr Opin Genes Dev 2: 293–298.
   PubMed Web of Science ®Google Scholar
• Frankel AD, Pabo CO (1988). Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55: 1189–1193.
   PubMed Web of Science ®Google Scholar
• Franks R, Rencic A, Gordon J, Zoltick PW, Curtis M, Knobler RL, Khalili K (1996). Formation of undifferen-tiated mesenteric tumors in transgenic mice expressing human neurotropic polyomavirus early protein. Onco-gene 12: 2573–2578.
   Google Scholar
• Frisque RJ (2001). Structure and function of JC virus T' pro-teins. J NeuroVirol 7: 293–297.
   PubMed Web of Science ®Google Scholar
• Frisque RJ, Bream GL, Cannella MT (1984). Human poly-omavirus JC virus genome. J Virol 51: 458–469.
   PubMed Web of Science ®Google Scholar
• Frisque RJ, White FA III (1992). The molecular biology of JC virus, causative agent of progressive multifocal leukoen-cephalopathy. In: Molecular neurovirology. Roos RP (ed). Totowa, NJ: Humana Press, pp 25–158.
   Google Scholar
• Genis P, Jett M, Bemton EV, Boyle T, Gelbard HA, Dzenko K, Keane RW, Resnick L, Mizrachi Y, Volsky DJ, Epstein LG, Gendelman HE (1992). Cytokines and arachidonic metabolites produced during the human immunodefi-ciency virus (HIV)-infected macrophage-astroglia inter-action: impications for the neuropathogenesis of HIV disease. J Exp Med 176: 1703–1718.
   Google Scholar
• Gordon J, Khalili K (1998). The human polyomavirus, JCV, and neurological diseases. Int j Mol Med 1: 647–655.
   Google Scholar
• Haggerty S, Walker DL, Frisque RJ (1989). JC virus-simian virus 40 genomes containing heterologous regulatory signals and chimeric early regions: identification of re-gions restricting transformation by JC virus. J Virol 63: 2180–2190.
   Google Scholar
• Henson J, Saffer J, Fumeaux H (1992). The transcription fac-tor Sp1 binds to the JC virus promoter and is selectively expressed in glial cells in human brain. Ann Neurol 32: 72–77.
   PubMedGoogle Scholar
• Howard CM, Claudio PP, Gallia GL, Gordon J, Giordano GG, Hauck WW, Khalili K, Giordano A (1998). Retinoblastoma-related protein pRb2/p130 suppresses tumor growth in vivo. J Nail Cancer Inst 90: 1451–1460.
   PubMed Web of Science ®Google Scholar
• Kenney S, Natarajan V, Strike D, Khoury G, Salzman NP (1984). JC virus enhancer-promoter active in human brain cells. Science 226: 1337–1339.
   PubMedGoogle Scholar
• Kerr D, Chang CF, Chen N, Gallia GL, Raj G, Schwartz B, Khalili K (1994). Transcription of a human neurotropic virus promoter in glial cells: effect of YB-1 on expression of the JC virus late gene. J Virol 68: 7637–7643.
   PubMedGoogle Scholar
• Khalili K, Feigenbaum L, Khoury G (1987). Evidence for a shift in 5'-termini of early viral RNA during the lytic cycle of JC virus. Virology 158: 469–472.
   Google Scholar
• Krynska B, Del Valle L, Croul S, Gordon J, Katsetos CD, Carbone M, Giordano A, Khalili K (1999). Detection of human neurotropic JC virus DNA sequence and expres-sion of the viral oncogenic protein in pediatric medul-loblastomas. Proc Natl Acad Sci USA 96: 11519–11524.
   PubMed Web of Science ®Google Scholar
• Laghi L, Randolph AE, Chauhan DP, Marra G, Major EO, Neel JV, Boland CR (1999). JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Nail Acad Sci US A 96: 7484–7489.
   PubMed Web of Science ®Google Scholar
• Lashgari M, Tada H, Amini S, Khalili K (1989). Regula-tion of JCVL promoter function. Transactivation of JCVL promoter by JCV and 5V40 early proteins. Virology 170: 292–295.
   Google Scholar
• London WT, Houff SA, Madden DL, Fuccillo DA, Gravell M, Wallen WC, Palmer AE, Sever JL, Padgett BL, Walker DL, ZuRhein GM, Ohashi T (1978). Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus). Science 201: 1246–1249.
   PubMed Web of Science ®Google Scholar
• London WT, Houff SA, McKeever PE, Wallen WC, Sever JL, Padgett BL, Walker DL (1983). Viral-induced astro-cytomas in squirrel monkeys. Prog Clin Biol Res 105: 227–237.
   Google Scholar
• Lynch KJ, Frisque RJ (1990). Identification of critical ele-ments within the JC virus DNA replication origin. J Virol 64: 5812–5822.
   PubMedGoogle Scholar
• Lynch KJ, Frisque RJ (1991). Factors contributing to the re-stricted DNA replicating activity of JC virus. Virology 180: 306–317.
   Google Scholar
• Lynch KJ, Haggerty S, Frisque RJ (1994). DNA replication of chimeric JC virus-simian virus 40 genomes. Virology 204: 819–822.
   Google Scholar
• Major EO, Amemiya K, Tornatore C, Houff SA, Berger JR (1992). Pathogenesis and molecular biology of pro-gressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbic)] Rev 5: 49–73.
   PubMed Web of Science ®Google Scholar
• Margolskee RF, Nathans D (1983). Suppression of a VP1 mutant of simian virus 40 by missense mutations in ser-ine codons of the viral Agnoproteingene. J Virol 48: 405–409.
   PubMed Web of Science ®Google Scholar
• Mertz JE, Murphy A, Barkan A (1983). Mutants deleted in the Agnoproteingene of simian virus 40 define a new complementation group. J Virol 48: 405–409.
   Google Scholar
• Neel JV (1999). The Colonel Harlan D Sanders Award Ad-dress for 1998: JC virus and its possible role in oncoge-nesis. Am J Med Genet 83: 152–156.
   Google Scholar
• Ng SC, Mertz JE, Sanden-Will S, Bina M (1985). Simian virus 40 maturation in cells harboring mutants deleted in the Agnoproteingene. J Biol Chem 260: 1127–1132.
   Google Scholar
• Piatak M, Subramanian KN, Roy P, Weissman SM (1981). Messenger RNA production by viable simian virus 40 mutants with deletions in the leader regionz. J Mol Biol 153: 589–618.
   PubMed Web of Science ®Google Scholar
• Raj GV, Khalili K (1994). Identification and characteriza-tion of a novel GGA/C-binding protein, GBP-i, that israpidly inducible by cytokines. Mol Cell Biol 14: 7770–7781.
   PubMedGoogle Scholar
• Raj GV, Khalili K (1995). Transcriptional regulation: lessons from the human neurotropic polyomavirus, JCV. Virol-ogy 213: 283–291.
   PubMed Web of Science ®Google Scholar
• Ranganathan PN, Khalili K (1993). The transcriptional en-hancer element, kappa B, regulates promoter activity of the human neurotropic virus, JCV, in cells derived from the CNS. Nucleic Acids Res 21: 1959–1964.
   PubMedGoogle Scholar
• Rencic A, Gordon J, Otte J, Curtis M, Kovatich A, Zoltick P, Khalili K, Andrews D (1996). Detection of JC virus DNA sequence and expression of the viral oncoprotein, tu-mor antigen, in brain of i=unocompetent patient with oligoastrocytoma. Proc Natl Acad Sci U S A 93: 7352–7357.
   Google Scholar
• Renner K, Leger H, Wegner M (1994). The POU doamin protein Tst-1 and papovaviral large tumor antigen func-tion synergistically to stimulate glia-specific gene ex-pression of JC virus. Proc Natl Acad Sci USA 91: 6433–6437.
   Google Scholar
• Richardson EP (1961). Progressive multifocal encephalopa-thy. N Engl j Med 265: 815–823.
   PubMed Web of Science ®Google Scholar
• Safak M, Barruccco R, Darbinyan A, Okada Y, Nagashima K, Khalili K (2001). Interaction of JC virus agno pro-tein with T antigen modulates transcription and repli-cation of the viral genome in glial cells. J Virol 75: 1476–1486.
   Google Scholar
• Safak M, Gallia GL, Ansari SA, Khalili K (1999a). Physical and functional interaction between the Y-box binding protein YB-1 and human polyomavirus JC virus large T antigen. J Virol 73: 10146–10157.
   PubMedGoogle Scholar
• Safak M, Gallia GL, Khalili K (1999b). A 23-bp sequence element from human neurotropic JC virus is responsive to NF-kappa B subunits. Virology 262: 178–189.
   Google Scholar
• Safak M, Gallia GL, Khalili K (1999c). Reciprocal interac-tion between two cellular proteins, Puralpha and YB- 1, modulates transcriptional activity of JCV•CY in glial cells. Mol Cell Biol 19: 2712–2723.
   PubMedGoogle Scholar
• Safak M, Sadowska B, Barrucco R, Khalili K (2002). Func-tional interaction between JC virus late regulatory agno-protein and cellular Y-box binding transcription factor, YB-1. J Virol 76: 3828–3838.
   Google Scholar
• Small JA, Khoury G, Jay G, Howley PM, Scangos GA (1986b). Early regions of JC virus and BK virus induce distinct and tissue-specific tumors in transgenic mice. Proc Natl Acad Sci US A 83: 8288–8292.
   PubMedGoogle Scholar
• Small JA, Scangos GA, Cork L, Jay G, Khoury G (1986a). The early region of human papovavirus JC induces dys-myelination in transgenic mice. Cell 46: 13–18.
   PubMedGoogle Scholar
• Swenson JJ, Trowbridge PW, Frisque RJ (1996). Replication activity of JC virus large T antigen phophorylation and zinc finger domain mutants. J NeuroVirol 2: 78–86.
   Web of Science ®Google Scholar
• Tada H, Lashgari MS, Khalili K (1991). Regulation of JCVL promoter function: evidence that a pentanu-cleotide "silencer" repeat sequence AGGGAAGGGA down-regulates transcription of the JC virus late pro-moter. Virology 180: 327–338.
   Google Scholar
• Tada H, Lashgari M, Rappaport J, Khalili K (1989). Cell type-specific expression of JC virus early promoter is deter-mined by positive and negative regulation. J Virol 63: 463–466.
   PubMedGoogle Scholar
• Varakis J, Zu Rhein GM, Padgett BL, Walker DL (1978). In-duction of peripheral neuroblastomas in Syrian ham-sters after injection of neonates with JC virus. Cancer Res 38: 1718–1722.
   Google Scholar
• Walker DL, Padgett BL, Zu Rhein GM, Albert AE, Marsh RF (1973). Human papovavirus (JC): induction of brain tumors in hamsters. Science 181: 674–676.
   PubMed Web of Science ®Google Scholar
• Wegner M, Drolet DW, Rosenfeld MG (1993). Regulation of JC virus by the POU-domain transcription factor Tst-1: implications for progressive multifocal leukoen-cephalopathy. Proc Natl Acad Sci US A 90: 4743–4747.
   PubMedGoogle Scholar